225 related articles for article (PubMed ID: 32921478)
1. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
Zhang ZQ; Shi BS; Lu W; Liu DP; Huang D; Feng YL
Gastroenterol Hepatol; 2020 Nov; 43(9):526-536. PubMed ID: 32921478
[TBL] [Abstract][Full Text] [Related]
2. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
[TBL] [Abstract][Full Text] [Related]
3. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
Chang XJ; Sun C; Chen Y; Li XD; Yu ZJ; Dong Z; Bai WL; Wang XD; Li ZQ; Chen D; Du WJ; Liao H; Jiang QY; Sun LJ; Li YY; Zhang CH; Xu DP; Chen YP; Li Q; Yang YP
World J Gastroenterol; 2019 Aug; 25(32):4764-4778. PubMed ID: 31528100
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
[TBL] [Abstract][Full Text] [Related]
5. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.
Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D
Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941
[TBL] [Abstract][Full Text] [Related]
7. Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection.
Zhang ZQ; Shi BS; Lu W; Huang D; Wang YB; Feng YL
J Virol Methods; 2021 Oct; 296():114226. PubMed ID: 34217779
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
[TBL] [Abstract][Full Text] [Related]
9. HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues.
Wang B; Carey I; Bruce M; Montague S; Dusheiko G; Agarwal K
J Viral Hepat; 2018 Aug; 25(8):886-893. PubMed ID: 29532589
[TBL] [Abstract][Full Text] [Related]
10. Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.
Chan HLY; Yasuda S; Wong GLH; Tada T; Chan CKM; Kumada T; Tse YK; Wong VWS; Toyoda H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2202-2209. PubMed ID: 32293740
[TBL] [Abstract][Full Text] [Related]
11. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
[TBL] [Abstract][Full Text] [Related]
12. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
Chen EQ; Wang ML; Tao YC; Wu DB; Liao J; He M; Tang H
J Viral Hepat; 2019 May; 26(5):586-595. PubMed ID: 30632235
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
[TBL] [Abstract][Full Text] [Related]
14. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Aliment Pharmacol Ther; 2018 Jan; 47(1):43-54. PubMed ID: 29035003
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy.
Chuaypen N; Posuwan N; Chittmittraprap S; Hirankarn N; Treeprasertsuk S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
Clin Microbiol Infect; 2018 Mar; 24(3):306.e7-306.e13. PubMed ID: 28750917
[TBL] [Abstract][Full Text] [Related]
16. Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients.
Zhao J; Bian D; Liao H; Wang Y; Ren Y; Jiang Y; Liu S; Chen X; Hu Z; Duan Z; Lu F; Zheng S
Front Cell Infect Microbiol; 2023; 13():1083912. PubMed ID: 37065191
[TBL] [Abstract][Full Text] [Related]
17. A critique and systematic review of the clinical utility of hepatitis B core-related antigen.
Adraneda C; Tan YC; Yeo EJ; Kew GS; Khakpoor A; Lim SG
J Hepatol; 2023 Apr; 78(4):731-741. PubMed ID: 36586590
[TBL] [Abstract][Full Text] [Related]
18. Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood.
Wu JF; Tai CS; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):663-669.e1. PubMed ID: 35240329
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B.
Zhang ZQ; Zhang XN; Lu W; Wang YB; Weng QC; Feng YL
BMC Gastroenterol; 2017 Dec; 17(1):140. PubMed ID: 29202690
[TBL] [Abstract][Full Text] [Related]
20. Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
Carey I; Gersch J; Wang B; Moigboi C; Kuhns M; Cloherty G; Dusheiko G; Agarwal K
Hepatology; 2020 Jul; 72(1):42-57. PubMed ID: 31701544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
